Literature DB >> 17719794

DJ-1 (PARK7) is associated with 3R and 4R tau neuronal and glial inclusions in neurodegenerative disorders.

Ravindran Kumaran1, Ann Kingsbury, Ian Coulter, Tammaryn Lashley, David Williams, Rohan de Silva, David Mann, Tamas Revesz, Andrew Lees, Rina Bandopadhyay.   

Abstract

Mutations in the DJ-1 gene are associated with autosomal recessive Parkinson's disease (PD), but its role in disease pathogenesis is unknown. This study examines DJ-1 immunoreactivity (DJ-1 IR) in a variety of neurodegenerative disorders, Alzheimer's disease (AD), frontotemporal lobar degeneration (FTLD) with Pick bodies, FTLD with MAPT mutations, progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD), in which hyperphosphorylated tau inclusions are the major pathological signature. DJ-1 IR was seen in a subset of neurofibrillary tangles (NFTs), neuropil threads (NTs), and neurites in extracellular plaques in AD; tau inclusions in AD contained both 3R and 4R tau. A subset of Pick bodies in FTLD showed DJ-1 IR. In PSP, DJ-1 IR was present in a few NFTs, NTs and glial cell inclusions. In CBD, DJ-1 IR was seen only in astrocytic plaques. In cases of FTLD with MAPT mutations that were 4R tau positive (i.e. N279K and exon 10+16 mutations), DJ-1 IR was present mostly in oligodendroglial coiled bodies. However, in MAPT R406W mutation cases, DJ-1 IR was associated mainly with NFTs and NTs and these were both 3R and 4R tau positive. No DJ-1 IR was present in FTLD with ubiquitin inclusions (FTLD-U). In AD and FTLD with Pick bodies, DJ-1 protein was enriched in the sarkosyl-insoluble fractions of frozen brain tissue containing insoluble hyperphosphorylated tau, thus strengthening the association of DJ-1 with tau pathology. Additionally using two-dimensional gel electrophoresis, we demonstrated accumulation of acidic pI isoforms of DJ-1 in AD brain, which may compromise its normal function. Our observations confirm previous findings that DJ-1 is present in a subpopulation of glial and neuronal tau inclusions in tau diseases and associated with both 3R and 4R tau isoforms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17719794     DOI: 10.1016/j.nbd.2007.07.012

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  14 in total

1.  Astrocyte-specific DJ-1 overexpression protects against rotenone-induced neurotoxicity in a rat model of Parkinson's disease.

Authors:  Briana R De Miranda; Emily M Rocha; Qing Bai; Amina El Ayadi; David Hinkle; Edward A Burton; J Timothy Greenamyre
Journal:  Neurobiol Dis       Date:  2018-04-09       Impact factor: 5.996

Review 2.  Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial.

Authors:  Khalid Iqbal; Xiaochuan Wang; Julie Blanchard; Fei Liu; Cheng-Xin Gong; Inge Grundke-Iqbal
Journal:  Biochem Soc Trans       Date:  2010-08       Impact factor: 5.407

3.  Oxygen Supplementation Improves Protein Milieu Supportive of Protein Synthesis and Antioxidant Function in the Cortex of Alzheimer's Disease Model Mice-a Quantitative Proteomic Study.

Authors:  Hao Wang; Xiaoyu Hong; Shuiming Li; Yong Wang
Journal:  J Mol Neurosci       Date:  2017-09-21       Impact factor: 3.444

4.  L10p and P158DEL DJ-1 mutations cause protein instability, aggregation, and dimerization impairments.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  J Neurosci Res       Date:  2010-11-01       Impact factor: 4.164

Review 5.  Mechanisms of tau-induced neurodegeneration.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong; Alejandra Del C Alonso; Inge Grundke-Iqbal
Journal:  Acta Neuropathol       Date:  2009-01-30       Impact factor: 17.088

6.  The E163K DJ-1 mutant shows specific antioxidant deficiency.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  Brain Res       Date:  2008-09-16       Impact factor: 3.252

7.  Parkinson's disease-associated DJ-1 mutations increase abnormal phosphorylation of tau protein through Akt/GSK-3β pathways.

Authors:  Yangang Wang; Weiping Liu; Xiaosheng He; Fei Zhou
Journal:  J Mol Neurosci       Date:  2013-08-27       Impact factor: 3.444

Review 8.  Splicing: is there an alternative contribution to Parkinson's disease?

Authors:  Valentina La Cognata; Velia D'Agata; Francesca Cavalcanti; Sebastiano Cavallaro
Journal:  Neurogenetics       Date:  2015-05-16       Impact factor: 2.660

9.  Deep brain stimulation induces rapidly reversible transcript changes in Parkinson's leucocytes.

Authors:  Lilach Soreq; Hagai Bergman; Yael Goll; David S Greenberg; Zvi Israel; Hermona Soreq
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

10.  Increased DJ-1 expression under oxidative stress and in Alzheimer's disease brains.

Authors:  Stéphanie Baulac; Hope Lu; Jennifer Strahle; Ting Yang; Matthew S Goldberg; Jie Shen; Michael G Schlossmacher; Cynthia A Lemere; Qun Lu; Weiming Xia
Journal:  Mol Neurodegener       Date:  2009-02-25       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.